NEOSCOPE: A randomized phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma

Mukherjee, S, Hurt, CN, Gwynne, S et al. (15 more authors) (2017) NEOSCOPE: A randomized phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma. European Journal of Cancer, 74. pp. 38-46. ISSN 0959-8049

Abstract

Metadata

Authors/Creators:
  • Mukherjee, S
  • Hurt, CN
  • Gwynne, S
  • Sebag-Montefiore, D
  • Radhakrishna, G
  • Gollins, S
  • Hawkins, M
  • Grabsch, HI ORCID logo https://orcid.org/0000-0001-9520-6228
  • Jones, G
  • Falk, S
  • Sharma, R
  • Bateman, A
  • Roy, R
  • Ray, R
  • Canham, J
  • Griffiths, G
  • Maughan, T
  • Crosby, T
Copyright, Publisher and Additional Information: © 2017 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/ licenses/by/4.0/).
Keywords: Oesophageal; Chemotherapy; Radiotherapy; Surgery; Neo-adjuvant; Randomised phase II
Dates:
  • Accepted: 4 December 2016
  • Published (online): 8 February 2017
  • Published: March 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Pathology & Tumour Biology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 24 Jan 2017 12:42
Last Modified: 05 Oct 2017 16:25
Published Version: https://doi.org/10.1016/j.ejca.2016.11.031
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.ejca.2016.11.031

Share / Export

Statistics